IDEAYA Biosciences Inc. (30J)
XSTU
Real-time Data
06:00 AM
Day's Range
32.1752 wk Range
22.20Overview - 30J - IDEAYA Biosciences Inc.
Key Statistics
Valuation
Enterprise Value
2.07B
P/E (Trailing)
‪-25.14‬
PEG Ratio
‪-0.65‬
Price / Sales (TTM)
‪13.37‬
Price / Book
‪2.98‬
EV / EBITDA
‪-11.04‬
Profitability
Profit Margin
‪-74.75%‬
Operating Margin
‪-1,380.72%‬
Return on Assets
‪-11.53%‬
Return on Equity
‪-16.21%‬
Ownership
Shares Outstanding
96.37M
Float
90.63M
Held by Insiders
‪2.19%‬
Held by Institutions
‪108.15%‬
Price stats
Beta
‪-0.07‬
50-Day Avg
‪32.69‬
200-Day Avg
‪29.07‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 30J - IDEAYA Biosciences Inc.
Peers - 30J - IDEAYA Biosciences Inc.
Peer Comparison
Compared with companies in Biotechnology listed on XSTU.
- 30JXSTUIDEAYA Biosciences Inc.3.10BMarket Cap+29.17%52-week change-25.15P/E (Trailing)‪-74.75%‬Profit Margin
- 6IBXSTUInnovent Biologics Inc.14.71BMarket Cap+6.26%52-week change—P/E (Trailing)‪86.53%‬Profit Margin
- 4KBXSTUKrystal Biotech, Inc.8.99BMarket Cap+52.99%52-week change43.02P/E (Trailing)‪54.81%‬Profit Margin
- 19XXSTUAxsome Therapeutics Inc.7.98BMarket Cap+41.36%52-week change-46.29P/E (Trailing)‪92.56%‬Profit Margin
- 2X10XSTUAbivax SA Sponsored ADR7.19BMarket Cap+12.50%52-week change-16.56P/E (Trailing)‪0.00%‬Profit Margin
- BSFAXSTUAni Pharmaceuticals, Inc.1.49BMarket Cap-19.23%52-week change16.21P/E (Trailing)‪11.07%‬Profit Margin
- AN6XSTUAnaptysBio Inc.1.48BMarket Cap+55.76%52-week change-96.80P/E (Trailing)—Profit Margin
Profile Summary - 30J - IDEAYA Biosciences Inc.
About
IDEAYA Biosciences Inc. is a precision medicine oncology company focused on discovering and developing targeted therapies for cancers defined by specific genetic alterations and biomarker profiles. The company combines small-molecule drug discovery, structural biology, bioinformatics, and translational biomarker…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
